LGALS9 and neoplasm: After loading oxaliplatin and antisense oligonucleotides targeting Galectin-9 into exosomes which were originated from MSCs, they exhibited superior antitumor effects than oxaliplatin and Galectin-9 inhibition alone in mice models with orthotopic tumor [157].